Results 121 to 130 of about 4,006,128 (388)
Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan+4 more
wiley +1 more source
Doxorubicin is an important class of anthracycline antitumor antibiotics produced by Streptomyces peucetius. The doxorubicin fermentation yield of the wild-type strain was very low, so it could not be produced directly by fermentation at an industrial ...
Songbai Yang+4 more
doaj +1 more source
United States Food and Drug Administration and the Pharmaceutical Industry [PDF]
Jane Garland
openalex +1 more source
Transparency and the pharmaceutical industry [PDF]
Carefully conducted and appropriately reported clinical trials are of fundamental importance in evidence-based medicine. This applies to both new and established treatments (see, for example, p291–2 of this issue). It is estimated that about half of all clinical trials are not reported; this is a problem of which we have been aware since 1986, if not ...
openaire +2 more sources
Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D [PDF]
This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S.
Toole, Andrew A.
core
Biofabrication aims at providing innovative technologies and tools for the fabrication of tissue‐like constructs for tissue engineering and regenerative medicine applications. By integrating multiple biofabrication technologies, such as 3D (bio) printing with fiber fabrication methods, it would be more realistic to reconstruct native tissue's ...
Waseem Kitana+2 more
wiley +1 more source
ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
At present, there is a tendency in Russia to switch domestic manufacturers of drugs from the system of purchases of chemical products to own production of active pharmaceutical ingredients.
K. O. Sidorov+2 more
doaj
This study presents novel anti‐counterfeiting tags with multilevel security features that utilize additional disguise features. They combine luminescent nanosized Ln‐MOFs with conductive polymers to multifunctional mixed‐matrix membranes and powder composites. The materials exhibit visible/NIR emission and matrix‐based conductivity even as black bodies.
Moritz Maxeiner+9 more
wiley +1 more source
Clinical Investigator, Patient, Pharmaceutical Industry, and Federal Agencies [PDF]
Irvine H. Page
openalex +1 more source
Indian Pharma Within Global Reach? [PDF]
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility nationally ...
Gehl Sampath, Padmashree
core